US Patent Issued to Latvian Institute of Organic Synthesis on May 12 for "Assay for measuring binding affinity for cardiolipin of biologically active compounds" (Latvian Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,625,142, issued on May 12, was assigned to Latvian Institute of Organic Synthesis (Riga, Latvia).

"Assay for measuring binding affinity for cardiolipin of biologically active compounds" was invented by Pavels Arsenjans (Riga, Latvia) and Pavels Dimitrijevs (Daugavpils, Latvia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for the evaluation of binding affinity of biologically active substances for cardiolipin based on acridinium salt utilization as a fluorescent probe."

The patent was filed on May 24, 2021, under Application No. 18/011,916.

*For further information, including images, charts and tables, please v...